DENTSPLY SIRONA (NASDAQ:XRAY) Cut to “Hold” at StockNews.com

StockNews.com lowered shares of DENTSPLY SIRONA (NASDAQ:XRAY) from a buy rating to a hold rating in a research report report published on Tuesday morning.

XRAY has been the topic of a number of other research reports. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Barrington Research cut their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Evercore ISI lowered their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, October 8th. Finally, Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $29.50.

DENTSPLY SIRONA Trading Up 0.6 %

NASDAQ XRAY opened at $18.64 on Tuesday. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60. The company’s 50-day moving average price is $23.54 and its 200-day moving average price is $25.20. The stock has a market cap of $3.71 billion, a PE ratio of -9.02, a PEG ratio of 1.85 and a beta of 1.02. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the company posted $0.49 earnings per share. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds have recently modified their holdings of XRAY. Scientech Research LLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter valued at about $846,000. Lazard Asset Management LLC increased its holdings in DENTSPLY SIRONA by 3.2% in the 1st quarter. Lazard Asset Management LLC now owns 4,080,795 shares of the medical instruments supplier’s stock worth $135,440,000 after buying an additional 126,351 shares during the period. VELA Investment Management LLC acquired a new position in DENTSPLY SIRONA in the 3rd quarter worth approximately $2,168,000. M&G Plc purchased a new position in DENTSPLY SIRONA during the 2nd quarter worth approximately $8,817,000. Finally, Virtu Financial LLC purchased a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at $1,027,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.